Austin Reaves: Everything you need to know

Austin Reaves

#15 SG

Los Angeles Lakers

Status

OUT - Oblique - Strain Expected Return: 2026-05-01

STATS

Career Averages

PTS

REB

AST

BLK

STL

15.8

3.9

4.5

0.3

0.8

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	TD3	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	51	45	34.5	23.3	4.7	5.5	0.4	1.1	3.0	6	0	2.3	6.4	36.0%	5.0	8.5	58.8%	7.3	14.9	49.0%	6.3	7.3	87.1%	0.6	4.1	2.2	1.9	+182	64.1%
2024-25	73	73	34.9	20.2	4.5	5.8	0.3	1.1	2.4	9	1	2.7	7.3	37.7%	3.8	6.9	54.7%	6.5	14.2	46.0%	4.4	5.0	87.7%	0.8	3.7	2.1	2.4	+195	61.6%
2023-24	82	57	32.1	15.9	4.3	5.5	0.3	0.8	2.1	9	1	1.9	5.1	36.7%	3.7	6.3	58.3%	5.6	11.5	48.6%	2.8	3.3	85.3%	0.7	3.6	1.9	2.6	-41	61.3%
2022-23	64	22	28.8	13.0	3.0	3.4	0.3	0.5	1.5	1	0	1.3	3.4	39.8%	2.7	4.3	63.1%	4.0	7.7	52.9%	3.6	4.1	86.4%	0.5	2.5	1.7	2.2	+214	68.7%
2021-22	61	19	23.2	7.3	3.2	1.8	0.3	0.5	0.7	1	1	0.9	2.7	31.7%	1.5	2.5	61.6%	2.4	5.2	45.9%	1.6	1.9	83.9%	0.7	2.4	1.4	2.8	+54	60.0%
Career	331	216	30.8	15.8	3.9	4.5	0.3	0.8	1.9	26	3	1.8	5.0	36.8%	3.3	5.7	58.4%	5.2	10.7	48.3%	3.6	4.2	86.5%	0.7	3.3	1.8	2.3	+604	63.0%

Career Averages

PTS

REB

AST

BLK

STL

16.7

4.5

4.2

0.3

0.7

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2024-25	5	5	39.2	16.2	5.4	3.6	0.6	0.2	2.8	3.0	9.4	31.9%	3.0	5.2	57.7%	6.0	14.6	41.1%	1.2	1.4	85.7%	0.8	4.6	3.6	1.3	-37	53.2%
2023-24	5	5	34.8	16.8	3.8	3.6	0.6	1.4	0.8	1.4	5.2	26.9%	4.6	7.4	62.2%	6.0	12.6	47.6%	3.4	3.8	89.5%	1.0	2.8	1.6	4.5	-9	58.9%
2022-23	16	16	36.2	16.9	4.4	4.6	0.2	0.6	1.6	2.4	5.5	44.3%	3.2	6.6	48.1%	5.6	12.1	46.4%	3.2	3.6	89.5%	1.3	3.2	2.4	2.9	+73	61.6%
Career	26	26	36.5	16.7	4.5	4.2	0.3	0.7	1.7	2.3	6.2	37.9%	3.4	6.5	52.7%	5.8	12.7	45.5%	2.8	3.2	89.2%	1.1	3.4	2.5	2.5	+27	59.3%

Preseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
10/14	PHX	L 113-104	31	25	4	2	1	1	4	6	2	33.3%	10	6	60.0%	16	8	50.0%	8	7	87.5%	0	4	0.5	-4	2	24	64.0%
10/12	GSW	W 126-116	22	21	3	3	1	1	5	4	2	50.0%	6	5	83.3%	10	7	70.0%	6	5	83.3%	1	2	0.6	+8	0	25	83.1%
10/3	PHX	L 103-81	20	20	3	2	0	0	2	5	1	20.0%	6	5	83.3%	11	6	54.5%	7	7	100.0%	0	3	1.0	-9	0	25	71.0%
Preseason Totals			24.9	22.0	3.3	2.3	0.7	0.7	3.7	5.0	1.7	33.3%	7.3	5.3	72.7%	12.3	7.0	56.8%	7.0	6.3	90.5%	0.3	3.0	0.6	-5	0.7	25.7	71.4%

Regular Season
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/2	OKC	L 139-96	26	15	4	1	0	0	4	3	2	66.7%	6	3	50.0%	9	5	55.6%	3	3	100.0%	0	4	0.3	-23	1	13	72.7%
3/31	CLE	W 127-113	36	19	6	4	1	2	5	9	2	22.2%	7	4	57.1%	16	6	37.5%	5	5	100.0%	1	5	0.8	+4	3	17	52.2%
3/30	WAS	W 120-101	27	19	3	9	0	1	5	4	0	0.0%	7	4	57.1%	11	4	36.4%	12	11	91.7%	1	2	1.8	+6	0	26	58.4%
3/27	BKN	W 116-99	40	26	8	5	0	1	2	7	4	57.1%	6	3	50.0%	13	7	53.8%	11	8	72.7%	0	8	2.5	+26	2	33	72.9%
3/25	IND	W 137-130	37	25	1	8	0	2	2	7	2	28.6%	9	5	55.6%	16	7	43.8%	9	9	100.0%	0	1	4.0	+14	3	28	62.6%
3/23	DET	L 113-110	39	24	2	5	1	0	3	6	2	33.3%	9	5	55.6%	15	7	46.7%	9	8	88.9%	0	2	1.7	-5	2	23	63.3%
3/21	ORL	W 105-104	40	26	7	5	1	2	3	8	2	25.0%	12	8	66.7%	20	10	50.0%	4	4	100.0%	2	5	1.7	+8	4	26	59.7%
3/19	MIA	W 134-126	39	18	5	4	0	0	2	7	2	28.6%	5	3	60.0%	12	5	41.7%	10	6	60.0%	1	4	2.0	+13	2	17	54.9%
3/18	HOU	W 124-116	38	14	3	8	1	0	1	3	1	33.3%	6	3	50.0%	9	4	44.4%	6	5	83.3%	0	3	8.0	+6	3	21	60.1%
3/16	HOU	W 100-92	40	15	3	5	1	4	1	8	0	0.0%	10	5	50.0%	18	5	27.8%	5	5	100.0%	1	2	5.0	+11	1	15	37.1%
3/14	DEN	W 127-125	45	32	7	6	1	1	3	8	3	37.5%	13	9	69.2%	21	12	57.1%	6	5	83.3%	1	6	2.0	+7	3	34	67.7%
3/12	CHI	W 142-130	38	30	5	7	0	1	3	7	4	57.1%	13	9	69.2%	20	13	65.0%	0	0	0.0%	1	4	2.3	+18	2	33	75.0%
3/10	MIN	W 120-106	38	31	7	8	0	0	1	10	4	40.0%	10	6	60.0%	20	10	50.0%	9	7	77.8%	1	6	8.0	+18	1	40	64.7%
3/8	NYK	W 110-97	38	25	4	5	1	3	1	6	3	50.0%	10	5	50.0%	16	8	50.0%	7	6	85.7%	0	4	5.0	+5	2	32	65.5%
3/6	IND	W 128-117	28	19	2	5	0	0	3	4	1	25.0%	10	5	50.0%	14	6	42.9%	7	6	85.7%	0	2	1.7	-12	6	13	55.6%
3/5	DEN	L 120-113	38	16	5	7	0	3	0	2	1	50.0%	9	5	55.6%	11	6	54.5%	4	3	75.0%	2	3	0.0	-4	2	27	62.7%
3/3	NOP	W 110-101	36	15	8	3	2	2	5	7	2	28.6%	8	2	25.0%	15	4	26.7%	5	5	100.0%	0	8	0.6	-1	3	12	43.6%
3/1	SAC	W 128-104	27	12	0	5	2	0	2	6	2	33.3%	3	1	33.3%	9	3	33.3%	4	4	100.0%	0	0	2.5	+15	0	11	55.8%
2/28	GSW	W 129-101	27	18	1	3	0	0	1	4	2	50.0%	7	5	71.4%	11	7	63.6%	2	2	100.0%	0	1	3.0	+22	1	19	75.8%
2/26	PHX	L 113-110	36	14	3	2	0	2	4	5	2	40.0%	7	3	42.9%	12	5	41.7%	2	2	100.0%	2	1	0.5	+9	4	6	54.3%
2/24	ORL	L 110-109	34	18	2	3	2	1	2	5	2	40.0%	11	4	36.4%	16	6	37.5%	4	4	100.0%	0	2	1.5	-4	1	14	50.7%
2/22	BOS	L 111-89	32	15	7	2	1	2	1	4	1	25.0%	6	3	50.0%	10	4	40.0%	7	6	85.7%	0	7	2.0	-14	1	24	57.3%
2/20	LAC	W 125-122	32	29	6	2	0	2	3	5	4	80.0%	10	5	50.0%	15	9	60.0%	7	7	100.0%	1	5	0.7	+0	1	31	80.2%
2/12	DAL	W 124-104	28	18	4	6	0	0	2	3	1	33.3%	7	4	57.1%	10	5	50.0%	9	7	77.8%	1	3	3.0	+6	2	23	64.5%
2/9	OKC	L 119-110	28	16	2	7	0	1	5	5	1	20.0%	9	5	55.6%	14	6	42.9%	3	3	100.0%	0	2	1.4	-14	3	14	52.2%
2/7	GSW	W 105-99	23	16	5	8	1	2	5	2	0	0.0%	8	5	62.5%	10	5	50.0%	7	6	85.7%	1	4	1.6	-1	2	26	61.2%
2/5	PHI	W 119-115	25	35	6	2	0	0	5	8	5	62.5%	9	7	77.8%	17	12	70.6%	7	6	85.7%	1	5	0.4	+5	0	38	87.2%
2/3	BKN	W 125-109	20	15	4	1	0	2	2	5	1	20.0%	4	2	50.0%	9	3	33.3%	10	8	80.0%	0	4	0.5	+10	3	13	56.0%
12/25	HOU	L 119-96	14	12	1	1	1	0	2	5	2	40.0%	3	3	100.0%	8	5	62.5%	0	0	0.0%	0	1	0.5	-7	0	11	75.0%
12/23	PHX	L 132-108	21	17	2	2	0	0	3	5	1	20.0%	6	5	83.3%	11	6	54.5%	5	4	80.0%	0	2	0.7	-17	4	10	64.4%
12/10	SAS	L 132-119	39	15	8	7	1	0	3	6	2	33.3%	10	4	40.0%	16	6	37.5%	1	1	100.0%	1	7	2.3	-5	5	15	45.6%
12/7	PHI	W 112-108	39	11	4	4	1	1	2	6	2	33.3%	10	1	10.0%	16	3	18.8%	5	3	60.0%	1	3	2.0	+1	0	6	30.2%
12/5	BOS	L 126-105	33	36	3	8	0	0	4	8	3	37.5%	10	6	60.0%	18	9	50.0%	17	15	88.2%	1	2	2.0	-9	0	41	70.6%
12/4	TOR	W 123-120	40	44	5	10	0	0	5	11	5	45.5%	10	8	80.0%	21	13	61.9%	15	13	86.7%	0	5	2.0	+6	3	51	79.7%
12/1	PHX	L 125-108	33	16	4	3	0	0	5	7	3	42.9%	5	3	60.0%	12	6	50.0%	1	1	100.0%	0	4	0.6	-11	2	12	64.3%
11/30	NOP	W 133-121	39	33	5	8	1	1	5	7	4	57.1%	8	5	62.5%	15	9	60.0%	12	11	91.7%	0	5	1.6	-2	1	42	81.4%
11/28	DAL	W 129-119	41	38	8	3	0	0	1	8	6	75.0%	7	6	85.7%	15	12	80.0%	9	8	88.9%	1	7	3.0	+3	2	50	100.2%
11/25	LAC	W 135-118	35	31	9	3	0	3	1	4	2	50.0%	12	9	75.0%	16	11	68.8%	7	7	100.0%	3	6	3.0	+19	3	41	81.2%
11/23	UTA	W 108-106	39	22	10	4	0	1	3	8	1	12.5%	9	6	66.7%	17	7	41.2%	8	7	87.5%	1	9	1.3	-1	2	24	53.6%
11/18	UTA	W 140-126	33	26	5	1	0	1	4	4	1	25.0%	7	6	85.7%	11	7	63.6%	12	11	91.7%	1	4	0.3	+10	3	28	79.9%
11/15	MIL	W 119-95	36	25	6	8	0	1	3	9	5	55.6%	8	4	50.0%	17	9	52.9%	3	2	66.7%	3	3	2.7	+14	4	27	68.2%
11/14	NOP	W 118-104	38	31	4	7	1	1	4	6	2	33.3%	10	7	70.0%	16	9	56.3%	13	11	84.6%	0	4	1.8	+16	3	36	71.4%
11/12	OKC	L 121-92	30	13	5	3	0	1	5	5	0	0.0%	7	4	57.1%	12	4	33.3%	6	5	83.3%	0	5	0.6	-24	3	7	44.4%
11/10	CHA	W 121-111	29	24	5	7	0	2	1	10	2	20.0%	7	5	71.4%	17	7	41.2%	11	8	72.7%	0	5	7.0	+18	2	30	54.9%
11/2	MIA	W 130-120	37	26	4	11	0	0	3	14	4	28.6%	8	5	62.5%	22	9	40.9%	5	4	80.0%	2	2	3.7	+7	3	23	53.7%
10/31	MEM	W 117-112	36	21	4	4	0	1	2	8	2	25.0%	6	3	50.0%	14	5	35.7%	9	9	100.0%	0	4	2.0	+15	2	22	58.5%
10/29	MIN	W 116-115	39	28	1	16	0	2	3	11	3	27.3%	13	6	46.2%	24	9	37.5%	7	7	100.0%	0	1	5.3	-1	1	35	51.7%
10/27	POR	L 122-108	39	41	4	5	0	3	8	8	3	37.5%	14	10	71.4%	22	13	59.1%	14	12	85.7%	0	4	0.6	+0	2	38	72.8%
10/26	SAC	W 127-120	39	51	11	9	0	2	2	10	6	60.0%	12	6	50.0%	22	12	54.5%	22	21	95.5%	1	10	4.5	+22	1	69	80.5%
10/24	MIN	W 128-110	36	25	7	11	0	0	1	5	2	40.0%	10	7	70.0%	15	9	60.0%	5	5	100.0%	0	7	11.0	+17	1	40	72.7%
10/21	GSW	L 119-109	36	26	5	9	0	2	5	5	1	20.0%	11	8	72.7%	16	9	56.3%	10	7	70.0%	1	4	1.8	-14	5	31	63.7%
Regular Season Totals			34.5	23.3	4.7	5.5	0.4	1.1	3.0	6.4	2.3	36.0%	8.5	5.0	58.8%	14.9	7.3	49.0%	7.3	6.3	87.1%	0.6	4.1	1.9	+182	2.2	28.8	64.1%

Austin Reaves: Breaking News

Reaves (oblique) has been ruled out for Tuesday's Game 2 of the first-round series against the Rockets. Reaves has missed the past six games due to a left oblique strain and will remain sidelined, as expected, while the Lakers look to extend their series lead to 2-0. An update on Reaves and Luka Doncic's (hamstring) status and potential return is expected in the coming days, but for now Los Angeles will continue to lean on Luke Kennard, who poured in 27 points in the Game 1 victory.

Reaves (oblique) is expected to miss at least one more week, per Khobi Price of The California Post. Neither Reaves nor Luka Doncic (hamstring) will be re-evaluated this week, leaving both players in serious jeopardy of missing Los Angeles' first-round playoff series against the Rockets. LeBron James will have to do the heavy lifting offensively for the Lakers, and the likes of Marcus Smart, Jake LaRavia and Rui Hachimura will also be asked to step up.

Reaves (oblique) will miss the rest of the 2025-26 regular season and is expected to be sidelined for around four to six weeks, according to Shams Charania of ESPN. Reaves not only will miss the rest of the regular season, but the injury will sideline him for around four to six weeks, meaning he's also expected to miss the first round of the 2026 NBA Playoffs. This is a huge loss for the Lakers, as they also recently lost Luka Doncic (hamstring), meaning the burden on offense will go through LeBron James. Reaves averaged 23.3 points, 4.7 rebounds, 5.5 assists and 1.1 steals per game in 51 regular-season contests, and his ability to return before the start of the playoffs will be key for the Lakers' chances to make a deep playoff run. Expect Luke Kennard and Bronny James to see expanded roles in the backcourt with both Reaves and Doncic sidelined.